Hermes Vector

Health

Preliminary study finds clue to help diagnose CTE in the living

A small study found higher levels of an Alzheimer's-related tau fragment in blood from people with advanced CTE, but researchers say much more work is needed.

By Hermes Vector

Also in: Español · Português · Français · 中文

Checked against 2 sourcesAPnbcboston.com
Illustration for: Preliminary study finds clue to help diagnose CTE in the living

In brief

  • A small study found higher levels of eMTBR-tau243 in blood from people with advanced CTE compared to healthy people.
  • The biomarker could not reliably identify early-stage CTE.
  • The findings were published by JAMA and presented at a scientific meeting in Japan.
  • Researchers say much larger studies are needed to confirm any connection.

Preliminary study finds clue to help diagnose CTE in the living

Scientists have found a preliminary clue that measuring a toxic protein tied to Alzheimer's disease might one day help diagnose chronic traumatic encephalopathy, or CTE, in living people, according to reporting by The Associated Press.

CTE is a brain disease linked to concussions and other brain trauma. Doctors currently evaluate symptoms such as mood swings and memory loss to try to tell if patients may have CTE. But other diseases cause similar symptoms, and a CTE diagnosis can only be confirmed by examining the brain after death.

The new clue involves a protein called tau that normally supports neurons but becomes abnormal in Alzheimer's, tangling inside those nerve cells. Researchers at Washington University in St. Louis were using autopsy samples to study a tau fragment called eMTBR-tau243 that may help track those tangles when they found something unusual: a patient with high levels of that biomarker even though records showed the person didn't have Alzheimer's but advanced CTE instead.

The researchers turned to a larger collection of autopsied brain and other samples, and eventually tested blood stored from 11 people who had been classified as having CTE. Compared to healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study coauthor Chihiro Sato, a WashU assistant neurology professor. That biomarker couldn't reliably identify early-stage CTE.

It is an interesting but very preliminary finding, requiring far larger studies to see if there is a real connection, cautioned Dr. Rudolph Castellani, a neuropathologist at Northwestern University who wasn't involved with the research.

Abnormal tau is found in several brain diseases, many of which can overlap in older adults, adding to the difficulty in teasing apart its role in any one disease, including CTE. Sato, who studies such tauopathies, also stressed much more research is needed.

The findings were published late Friday by the medical journal JAMA and presented at a scientific meeting in Japan.

Why it matters

A reliable way to diagnose CTE in living people does not currently exist. Confirmation requires examination of the brain after death, which limits research and clinical care for people with repeated head trauma.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.

Questions readers ask

What is the potential method for diagnosing CTE in living people?
Scientists found that measuring a toxic protein called eMTBR-tau243 might help diagnose chronic traumatic encephalopathy, or CTE, in living people.
How is CTE currently diagnosed?
Doctors currently evaluate symptoms such as mood swings and memory loss, but a CTE diagnosis can only be confirmed by examining the brain after death.
What did researchers at Washington University in St. Louis discover about the eMTBR-tau243 biomarker?
They found that levels of eMTBR-tau243 were higher in 11 people with advanced CTE compared to healthy people, though it could not reliably identify early-stage CTE.
Why is this finding considered preliminary?
The finding requires far larger studies to see if there is a real connection, and abnormal tau is found in several brain diseases that can overlap in older adults.
Where and when were the findings published?
The findings were published late Friday by the medical journal JAMA and presented at a scientific meeting in Japan.

The day's checked news, by email

One short email a day with the top stories. Free, and you can unsubscribe in one click.

Or follow for the latest news:

How do you feel about this story?

Comments 0

No comments yet. Start the discussion.

Health

US on track to lose measles elimination status after 26 years

The United States may lose its measles elimination status as the Pan American Health Organization reviews whether the virus has spread continuously for more than a year amid rising cases and falling vaccination rates.

Checked against 6 sourcesCNNthe74million.orgnbc26.com+3 more